Market News

Latest financial and economic news and analysis

Accesswire News Agency
Yesterday•Accesswire
Stocks Medium Importance Neutral
Ucore Announces $60 Million Bought Deal Public Offering of Common Shares

Ucore Announces $60 Million Bought Deal Public Offering of Common Shares

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, NS / ACCESS Newswire / August 6, 2026 / Ucore Rare Metals Inc. (TSX-V: UCU)(OTCQX: UURAF ) ("Ucore" or the "Company") is pleased to announce that it has entered into an agreement with Red Cloud Securities Inc. as sole bookrunner and co-lead underwriter, and B. Riley Securities, Inc., as co-lead underwriter, on behalf of a syndicate of underwriters (collectively, the "Underwriters"), pursuant to which the Underwriters have agreed to purchase, on a "bought deal" basis, 21,430,000 common shares (the "Common Shares") of the Company at a price of C$2.80 per Common Share (the "Issue Price") for aggregate gross proceeds to the Company of C$60,004,000 (the "Offering").

Related Symbols 1
UURAF UURAF
Source: Accesswire
Visit Source
0 0 0
Read More
Comment
Zacks Investment Research News Agency
Yesterday•Zacks Investment Research
Stocks Medium Importance Neutral
Here's Why Lithium Americas Corp. (LAC) Fell More Than Broader Market

Here's Why Lithium Americas Corp. (LAC) Fell More Than Broader Market

Lithium Americas Corp. (LAC) reached $3.02 at the closing of the latest trading day, reflecting a -2.27% change compared to its last close.

Related Symbols 1
LAC LAC
Source: Zacks Investment Research
Visit Source
Special Offer LiteFinance Start Trading
0 0 0
Read More
Comment
PRNewsWire News Agency
Yesterday•PRNewsWire
Stocks Medium Importance Neutral
PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit

PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit

NEW YORK, Aug. 6, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024 and February 25, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed.

Related Symbols 1
PRCT PRCT
Source: PRNewsWire
Visit Source
0 0 0
Read More
Comment
Zacks Investment Research News Agency
Yesterday•Zacks Investment Research
Stocks Medium Importance Neutral
Maplebear (CART) Misses Q2 Earnings Estimates

Maplebear (CART) Misses Q2 Earnings Estimates

Maplebear (CART) came out with quarterly earnings of $0.45 per share, missing the Zacks Consensus Estimate of $0.55 per share. This compares to earnings of $0.41 per share a year ago.

Related Symbols 1
CART CART
Source: Zacks Investment Research
Visit Source
Special Offer LiteFinance Start Trading
0 0 0
Read More
Comment
Zacks Investment Research News Agency
Yesterday•Zacks Investment Research
Stocks Medium Importance Neutral
The Trade Desk (TTD) Misses Q2 Earnings and Revenue Estimates

The Trade Desk (TTD) Misses Q2 Earnings and Revenue Estimates

The Trade Desk (TTD) came out with quarterly earnings of $0.34 per share, missing the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.41 per share a year ago.

Related Symbols 1
TTD TTD
Source: Zacks Investment Research
Visit Source
0 0 0
Read More
Comment
Zacks Investment Research News Agency
Yesterday•Zacks Investment Research
Stocks Medium Importance Neutral
Arcturus Therapeutics (ARCT) Reports Q2 Loss, Beats Revenue Estimates

Arcturus Therapeutics (ARCT) Reports Q2 Loss, Beats Revenue Estimates

Arcturus Therapeutics (ARCT) came out with a quarterly loss of $0.84 per share versus the Zacks Consensus Estimate of a loss of $1.07. This compares to a loss of $0.34 per share a year ago.

Related Symbols 1
ARCT ARCT
Source: Zacks Investment Research
Visit Source
0 0 0
Read More
Comment